Africa has used 60% of its Covid-19 vaccines, but don’t get too excited
Only 0,5% of the population is fully vaccinated, and the stalled J&J delivery has thrown a big spanner in the works
The delay in authorising Johnson & Johnson (J&J) vaccines for release after problems at a US company making the components could impact the whole continent and not only SA’s vaccine rollout, said Dr John Nkengasong, director of the Africa CDC, at his weekly Covid-19 update (https://africacdc.org/covid-19/) on Thursday.
“SA is not the only country affected. We are looking forward to using a lot of Johnson & Johnson vaccines. Our entire AVATT (African Vaccine Acquisition Task Team) strategy is underpinned by the need to have 270 million doses from J&J, with the option of taking up another 400 million,” he said.
Nkengasong said he had been in contact with the US Food and Drug Administration (FDA) and US Centers for Disease Control and Prevention (CDC) and hoped by Friday, or early next week, to have a comprehensive picture of what was going on. He stressed, however, that safety and human life came first...